KRAS G12D Mutation

Explore clinical trials studying KRAS G12D Mutation. Study availability and eligibility vary by location and protocol.

3 public trials 1 recruiting study

Refine in advanced search Browse all conditions

KRAS G12D Mutation trial results

Recruiting

NCT06667544

Conditions: KRAS G12D Mutation
Locations: Guangxi Medical University Cancer Hospital Nanning, Guangxi, China

Henan Cancer Hospital Zhengzhou, Henan, China

Union Hospital, Tongji Medical College, Huazhong University of Science and Technology Wuhan, Hubei, China

Zhejiang Cancer Hospital Hangzhou, Zhejiang, China

Not Yet Recruiting

NCT07668752

Conditions: Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +9 more
Locations: Shanghai Lung Cancer Center, Shanghai Key Laboratory of Thoracic Tumor Biotherapy, Shanghai Chest Hospital, Shanghai Jiao Tong University School of Medicine Shanghai, Shanghai Municipality, China

Active, Not Recruiting

NCT07023731

Conditions: Adenocarcinoma, Adenocarcinoma Of Esophagus, Adnexal Diseases, +61 more
Locations: Clinical Trial Site Phoenix, Arizona, United States

Clinical Trial Site Phoenix, Arizona, United States

Clinical Trial Site New Haven, Connecticut, United States

Clinical Trial Site Tampa, Florida, United States

View all 14 locations